Dishman Carbogen Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review
- June 18, 2026
- Posted by: Kunal Singla
- Category: News
Dishman Carbogen (NSE:DCAL) CMP: Rs 172.02 (2026). Sector: Pharmaceuticals and Healthcare. JM Financial: Neutral Rs 205. Kotak Securities: Neutral Rs 185. Consensus: Rs 195.
The Dishman Carbogen stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Dishman Carbogen share price prediction as one data point and not as a guarantee of future performance.
This article reviews every dimension of the Dishman Carbogen stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.
Click Here – Get Free Investment Predictions
What Analysts Predict for Dishman Carbogen Stock in 2026
Analyst consensus on the Dishman Carbogen stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and Kotak Securities. All figures are sourced from publicly available research and should be verified before publishing.
| Brokerage | Rating | Dishman Carbogen Stock Prediction (Rs) | Updated |
|---|---|---|---|
| JM Financial | Neutral | Rs 205 | 2026 |
| Kotak Securities | Neutral | Rs 185 | 2026 |
| Analyst Consensus | — | Rs 195 | 2026 |
The analyst target range for Dishman Carbogen reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Dishman Carbogen stock forecast from the current price of Rs 172.02 may or may not be realised by end of 2026.
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Dishman Carbogen Company Overview
Dishman Carbogen Amcis is a significant player in India’s pharmaceutical industry with a presence across domestic formulations, US generics and specialty segments. The Dishman Carbogen stock prediction for 2026 reflects both the pipeline growth potential and regulatory risk.
| Metric | Value |
|---|---|
| NSE Ticker | DCAL |
| Sector | Pharmaceuticals and Healthcare |
| CMP | Rs 172.02 (2026) |
| 52 Week High | — |
| 52 Week Low | — |
| Market Cap | — |
| P/E Ratio | — |
| Dishman Carbogen Stock Prediction Consensus (12M) | Rs 195 |
Dishman Carbogen Stock Prediction by Time Horizon
Analysts split the Dishman Carbogen share price prediction across time frames as near-term drivers differ materially from the long-term view.
Short-Term Dishman Carbogen Stock Prediction
The near-term Dishman Carbogen stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 172.02 are being watched closely. A short-term Dishman Carbogen share price prediction carries the most uncertainty of any time horizon.
12-Month Dishman Carbogen Stock Prediction
JM Financial targets Rs 205 (Neutral) and Kotak Securities targets Rs 185 (Neutral). Most desks refresh their Dishman Carbogen stock forecast within two to four weeks of each quarterly earnings print. The Dishman Carbogen share price prediction should be verified against the most recent analyst reports.
Long-Term Dishman Carbogen Stock Prediction
The long-term outlook for Dishman Carbogen is built on assumptions about demand recovery, margin expansion and revenue diversification in the Pharmaceuticals and Healthcare sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.
Dishman Carbogen Stock Forecast: Key Factors
The following four factors appear consistently in analyst research on Dishman Carbogen and are the primary inputs into the bull and bear case scenarios.
US Generic Revenue
US generics revenue is the most watched metric in the Dishman Carbogen stock forecast. USFDA approval timelines and price erosion rates directly affect the Dishman Carbogen share price prediction from most research desks.
Domestic Formulations Growth
Domestic formulation growth provides a stable base that supports the Dishman Carbogen stock prediction even when export growth faces headwinds.
R&D Pipeline
The depth and commercialization pace of the R&D pipeline is a key variable in the long-term Dishman Carbogen share price prediction. New product approvals are cited as catalysts for the Dishman Carbogen stock prediction.
EBITDA Margin
Sustained EBITDA margin expansion is typically the basis for the bullish Dishman Carbogen stock forecast. Margin recovery strengthens the Dishman Carbogen share price prediction from most research desks.
Dishman Carbogen Stock Prediction: Bull and Bear Scenarios
| Scenario | Dishman Carbogen Stock Prediction | Key Conditions |
|---|---|---|
| Bull Case | Rs 205 | Strong execution, margin improvement, favourable macro and sector re-rating |
| Base Case | Rs 195 | Steady performance, gradual recovery, margins hold, growth on track |
| Bear Case | Rs 165 | Demand deterioration, margin pressure, sector de-rating and macro headwinds |
The bull case Dishman Carbogen stock forecast of Rs 205 assumes most positive variables converge. The base case of Rs 195 is the analyst consensus and may or may not be achieved.
How Analysts Are Reading the Dishman Carbogen Stock Story
Analyst reviews of the Dishman Carbogen share price prediction highlight the company’s core strengths in Pharmaceuticals and Healthcare alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Dishman Carbogen is built on real business strengths set against real risks.
Key Risks to the Dishman Carbogen Stock Prediction
USFDA Regulatory Risk
Import alerts and warning letters from the USFDA are the most significant risks to the Dishman Carbogen stock prediction. A facility closure would force an immediate sharp revision to the Dishman Carbogen share price prediction.
Price Erosion in the US
Pricing pressure in US generics compresses the revenue per product and affects the Dishman Carbogen stock forecast. Aggressive price erosion pushes the Dishman Carbogen share price prediction toward the bear case.
R&D Execution Risk
Delays in clinical trials or approval failures affect the Dishman Carbogen stock prediction. The Dishman Carbogen share price prediction is particularly sensitive to key pipeline asset announcements.
Currency Risk
A strengthening rupee against the dollar reduces export realisation and affects the Dishman Carbogen stock forecast. Currency risk is embedded in conservative Dishman Carbogen share price prediction models.
How to Monitor the Dishman Carbogen Stock Forecast
Track the Dishman Carbogen share price prediction consensus quarterly. After every earnings release, most brokerages revise their Dishman Carbogen stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Dishman Carbogen is improving or deteriorating.
Compare the current price of Rs 172.02 with the analyst target range of Rs 205 to Rs 185. A wide target band reflects genuine uncertainty on Dishman Carbogen, so position size should reflect that range rather than the midpoint alone.
Review the Dishman Carbogen share price prediction every quarter against key business metrics for the Pharmaceuticals and Healthcare sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.
Check Live Dishman Carbogen Fundamentals on the Univest Screener
Conclusion
The Dishman Carbogen stock prediction for 2026 reflects the analyst community’s assessment of Dishman Carbogen Amcis’s competitive position, earnings trajectory and macro environment. JM Financial holds a Neutral stance with a target of Rs 205 while Kotak Securities has a Neutral rating with a target of Rs 185, giving an analyst consensus of Rs 195.
The Dishman Carbogen stock forecast is set against near-term risks that make the Dishman Carbogen share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Dishman Carbogen share price target changes over time is more valuable than relying on any single estimate.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Dishman Carbogen in real time.
Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Dishman Carbogen Stock Prediction 2026
What is the Dishman Carbogen stock prediction for 2026?
Ans. The Dishman Carbogen stock prediction for 2026 is based on analyst consensus from JM Financial and Kotak Securities. The consensus target is Rs 195. All estimates may or may not be achieved.
Is the Dishman Carbogen stock prediction bullish or bearish?
Ans. JM Financial has a Neutral rating with target Rs 205. Kotak Securities has a Neutral rating with target Rs 185. The Dishman Carbogen stock forecast reflects genuine analyst diversity of opinion.
What is the Dishman Carbogen share price prediction based on fundamentals?
Ans. The Dishman Carbogen share price prediction rests on the US generic pipeline, domestic growth, EBITDA margin and regulatory compliance track record. Analysts tracking Dishman Carbogen closely cite these as the primary drivers of the 2026 outlook.
What is the long-term Dishman Carbogen stock prediction?
Ans. The long-term outlook assumes Dishman Carbogen sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 195 is the nearest reliable anchor point.
What are the key risks to the Dishman Carbogen stock prediction?
Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Dishman Carbogen should be read alongside its risk assumptions.
What does the Dishman Carbogen stock forecast say for 2026?
Ans. JM Financial: Neutral target Rs 205. Kotak Securities: Neutral target Rs 185. These Dishman Carbogen share price prediction estimates may or may not prove accurate.
Where can I track the latest Dishman Carbogen stock prediction?
Ans. Track the latest analyst targets and price movements for Dishman Carbogen on the NSE and BSE websites and on the Univest app and screener for live data.
